Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1905 W.Taylor Street, Room 149, Chicago, IL 60615, USA.
Invest Ophthalmol Vis Sci. 2011 Nov 17;52(12):8900-7. doi: 10.1167/iovs.11-7644.
To evaluate contrast threshold and contrast gain in patients with optic neuritis under conditions designed to favor mediation by either the inferred magnocellular (MC) or parvocellular (PC) pathway.
Achromatic and chromatic contrast discrimination was measured in 11 patients with unilateral or bilateral optic neuritis and in 18 age-matched controls with normal vision, using achromatic steady- and pulsed-pedestal paradigms to bias performance toward the MC or PC pathway, respectively. In addition, L-M chromatic discrimination at equiluminance was evaluated using the steady-pedestal paradigm. A physiologically plausible model could describe the data with parameters accounting for contrast gain and contrast sensitivity in the inferred MC or PC pathway. The fitted parameters from the eye affected by optic neuritis were compared with those from the normal eye using generalized estimation equation (GEE) models that can account for within-subject correlations.
Compared with normal eyes, the affected eyes had significantly higher saturation parameters when measured with both the achromatic pulsed-pedestal paradigm (GEE: β [SE] = 0.35 [0.06]; P < 0.001) and the chromatic discrimination paradigm (β [SE] = 0.18 [0.08]; P = 0.015), suggesting that contrast gain in the inferred PC pathway is reduced; the affected eyes also had reduced absolute sensitivity in the inferred MC pathway measured with the achromatic steady-pedestal paradigm (β [SE] = 0.12 [0.04]; P = 0.005).
Optic neuritis produced large sensitivity losses mediated by the MC pathway and contrast gain losses in the inferred PC pathway. A clinical framework is presented for interpreting contrast sensitivity and gain loss to chromatic and achromatic stimuli in terms of retinal and postretinogeniculate loci contributions to detection and discrimination.
评估视神经炎患者在设计条件下的对比阈值和对比增益,这些条件旨在有利于推断的大细胞 (MC) 或小细胞 (PC) 通路的介导。
使用无彩色和彩色对比辨别测量了 11 名单侧或双侧视神经炎患者和 18 名年龄匹配的视力正常对照者,使用无彩色稳定和脉冲基底范式分别偏向于 MC 或 PC 通路的性能。此外,使用稳定基底范式评估等亮度下的 L-M 彩色辨别。一个生理上合理的模型可以用参数来描述数据,这些参数可以解释推断的 MC 或 PC 通路中的对比增益和对比敏感度。使用可以解释个体内相关性的广义估计方程 (GEE) 模型,比较受视神经炎影响的眼睛和正常眼睛的拟合参数。
与正常眼睛相比,受影响的眼睛在使用无彩色脉冲基底范式 (GEE:β [SE] = 0.35 [0.06];P < 0.001) 和彩色辨别范式 (β [SE] = 0.18 [0.08];P = 0.015) 测量时,饱和度参数显著更高,表明推断的 PC 通路中的对比增益降低;受影响的眼睛在使用无彩色稳定基底范式测量时,推断的 MC 通路中的绝对敏感性也降低 (β [SE] = 0.12 [0.04];P = 0.005)。
视神经炎导致 MC 通路介导的敏感性损失大,推断的 PC 通路中的对比增益损失。提出了一种临床框架,用于根据视网膜和视后神经节的贡献来解释对比敏感度和色觉和无彩色刺激的增益损失。